These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32991788)

  • 1. Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial.
    Koller D; Almenara S; Mejía G; Saiz-Rodríguez M; Zubiaur P; Román M; Ochoa D; Wojnicz A; Martín S; Romero-Palacián D; Navares-Gómez M; Abad-Santos F
    Hum Psychopharmacol; 2021 Jan; 36(1):1-12. PubMed ID: 32991788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics.
    Koller D; Almenara S; Mejía G; Saiz-Rodríguez M; Zubiaur P; Román M; Ochoa D; Navares-Gómez M; Santos-Molina E; Pintos-Sánchez E; Abad-Santos F
    Adv Ther; 2021 Feb; 38(2):1035-1054. PubMed ID: 33278020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of aripiprazole and olanzapine on pupillary light reflex and its relationship with pharmacogenetics in a randomized multiple-dose trial.
    Koller D; Saiz-Rodríguez M; Zubiaur P; Ochoa D; Almenara S; Román M; Romero-Palacián D; de Miguel-Cáceres A; Martín S; Navares-Gómez M; Mejía G; Wojnicz A; Abad-Santos F
    Br J Clin Pharmacol; 2020 Oct; 86(10):2051-2062. PubMed ID: 32250470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects.
    Koller D; Belmonte C; Lubomirov R; Saiz-Rodríguez M; Zubiaur P; Román M; Ochoa D; Carcas A; Wojnicz A; Abad-Santos F
    J Psychopharmacol; 2018 Nov; 32(11):1212-1222. PubMed ID: 30251598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Relationship Between Pharmacokinetics and the Safety of Aripiprazole and Its Cardiovascular Effects in Healthy Volunteers.
    Belmonte C; Ochoa D; Román M; Cabaleiro T; Talegón M; Sánchez-Rojas SD; Abad-Santos F
    J Clin Psychopharmacol; 2016 Dec; 36(6):608-614. PubMed ID: 27684290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study.
    Sun L; Yagoda S; Xue H; Brown R; Nangia N; McDonnell D; Rege B; von Moltke L; Darpo B
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109881. PubMed ID: 32004636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers.
    Zubiaur P; Soria-Chacartegui P; Koller D; Navares-Gómez M; Ochoa D; Almenara S; Saiz-Rodríguez M; Mejía-Abril G; Villapalos-García G; Román M; Martín-Vílchez S; Abad-Santos F
    Biomed Pharmacother; 2021 Jan; 133():111087. PubMed ID: 33378980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Effects of Antipsychotics on Adiposity and Insulin Sensitivity in Youths: A Randomized Clinical Trial.
    Nicol GE; Yingling MD; Flavin KS; Schweiger JA; Patterson BW; Schechtman KB; Newcomer JW
    JAMA Psychiatry; 2018 Aug; 75(8):788-796. PubMed ID: 29898210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of amisulpride, olanzapine, quetiapine, and aripiprazole single administration on c-Fos expression in vasopressinergic and oxytocinergic neurons of the rat hypothalamic supraoptic nucleus.
    Kiss A; Osacka J
    Endocr Regul; 2020 Apr; 54(2):77-84. PubMed ID: 32597151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of amisulpride, olanzapine, quetiapine, and aripiprazole single administration on c-Fos expression in vasopressinergic and oxytocinergic neurons of the rat hypothalamic paraventricular nucleus.
    Kiss A; Osacka J
    Neuropeptides; 2021 Jun; 87():102148. PubMed ID: 33887540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone.
    Gómez-Revuelta M; Pelayo-Terán JM; Juncal-Ruiz M; Vázquez-Bourgon J; Suárez-Pinilla P; Romero-Jiménez R; Setién Suero E; Ayesa-Arriola R; Crespo-Facorro B
    Int J Neuropsychopharmacol; 2020 Apr; 23(4):217-229. PubMed ID: 31974576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Cariprazine, Aripiprazole, and Olanzapine on Mouse Fibroblast Culture: Changes in Adiponectin Contents in Supernatants, Triglyceride Accumulation, and Peroxisome Proliferator-Activated Receptor-γ Expression.
    Bába LI; Kolcsár M; Kun IZ; Ulakcsai Z; Bagaméry F; Szökő É; Tábi T; Gáll Z
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31108997
    [No Abstract]   [Full Text] [Related]  

  • 13. c-Fos and FosB/ΔFosB colocalizations in selected forebrain structures after olanzapine, amisulpride, aripiprazole, and quetiapine single administration in rats preconditioned by two different mild stressors sequences.
    Kiss A; Osacka J
    Endocr Regul; 2020 Jan; 54(1):43-52. PubMed ID: 32597143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Fos expression response to olanzapine, amisulpride, aripiprazole, and quetiapine single administration in the rat forebrain: Effect of a mild stress preconditioning.
    Kiss A; Koprdova R; Osacka J; Pecenak J
    Neurochem Int; 2019 Jun; 126():187-194. PubMed ID: 30905743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjects.
    Cabaleiro T; López-Rodríguez R; Ochoa D; Román M; Novalbos J; Abad-Santos F
    Hum Psychopharmacol; 2013 May; 28(3):205-14. PubMed ID: 23559402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular olanzapine versus intramuscular aripiprazole for the treatment of agitation in patients with schizophrenia: A pragmatic double-blind randomized trial.
    Kittipeerachon M; Chaichan W
    Schizophr Res; 2016 Oct; 176(2-3):231-238. PubMed ID: 27461399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
    Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MG; Bilenberg N; Stenstrøm AD; Nyvang L; Madsen S; Werge TM; Lange T; Gluud C; Skoog M; Winkel P; Jepsen JRM; Fagerlund B; Correll CU; Fink-Jensen A
    Lancet Psychiatry; 2017 Aug; 4(8):605-618. PubMed ID: 28599949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching stable patients with schizophrenia from their oral antipsychotics to aripiprazole lauroxil: a post hoc safety analysis of the initial 12-week crossover period.
    Weiden PJ; Du Y; Liu CC; Stanford AD
    CNS Spectr; 2019 Aug; 24(4):419-425. PubMed ID: 29941057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.
    Johnsen E; Kroken RA; Løberg EM; Rettenbacher M; Joa I; Larsen TK; Reitan SK; Walla B; Alisauskiene R; Anda LG; Bartz-Johannessen C; Berle JØ; Bjarke J; Fathian F; Hugdahl K; Kjelby E; Sinkeviciute I; Skrede S; Stabell L; Steen VM; Fleischhacker WW
    Lancet Psychiatry; 2020 Nov; 7(11):945-954. PubMed ID: 33069317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.